Spontaneously remitting dermatomyositis

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 4, 2004, Pages 495-498

  Jordan, J R ^a   Paruthi, S ^a   Pichardo, R O ^a   Challa, V R ^a   Donofrio, P D ^a   Jorizzo, J L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Dermatomyositis; Remission

Indexed keywords

ACETYLSALICYLIC ACID; CLOBETASOL PROPIONATE; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CORTICOSTEROID; FLUOCINONIDE; MUSCLE ENZYME; NAPROXEN; SUNSCREEN; TACROLIMUS; TRIAMCINOLONE;

AGE; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE COURSE; DISEASE SEVERITY; ELECTROMYOGRAM; ENZYME BLOOD LEVEL; EXPERIENCE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; PRIORITY JOURNAL; REMISSION; SEX DIFFERENCE; SKELETAL MUSCLE; SKIN BIOPSY;

AGED; DERMATOMYOSITIS; FEMALE; HUMANS; MUSCLE, SKELETAL; REMISSION, SPONTANEOUS; SKIN;

EID: 3242781025     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00962.x     Document Type: Article

References (16)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 403-407.
2. Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 1991; 325: 1487-1498.
3. Stonecipher MR, Jorrizo JL, Monu J et al. Dermatomyositis with normal muscle enzyme concentration. Arch Dermatol 1994; 130: 1294-1299.
4. Drake LA, Dinehart SM, Farmer ER et al. Guidelines of care for dermatomyositis. American Academy of Dermatology. J Am Acad Dermatol 1996; 34: 824-829.
5. Stonecipher MR, Callen JF, Jorizzo JL. The red face: dermatomyositis. Clin Dermatol 1993; 11: 267-273.
6. Ghate J, Katsambas A, Augerinou G, Jorrizo JL. A therapeutic update on dermatomyositis/polymyositis. Int J Dermatol 2000; 39: 81-87.
7. Dawkins MA, Jorizzo JL, Walker FO et al. Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol 1998; 38: 397-404.
8. Biswas T, Miller FW, Takagaki Y, Plotz PH. An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum. J Immunol Methods 1987; 98: 243-248.
9. Plotz PH, Dalakas M, Leff RL et al. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989; 111: 143-157.
10. Whitaker JN. Inflammatory myopathy: a review of etiologic and pathogenetic factors. Muscle Nerve 1982; 5: 573-592.
11. Janis JF, Winkelmann RK. Histopathology of the skin in dermatomyositis. Arch Dermatol 1968; 97: 640-650.
12. Chen Z, Maize JC, Silver RM et al. Direct and indirect immunofluorescent findings in dermatomyositis. J Cutan Pathol 1985; 12: 18-27.
13. Baron M, Small P. Polymyositis/dermatomyositis: clinical features and outcome in 22 patients. J Rheumatol 1985; 12: 283-286.
14. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis and polymyositis. N Engl J Med 1992; 326: 363-367.
15. Boyd AS, Neldner KH. Therapeutic options in dermatomyositis/polymyositis. Int J Dermatol 1994; 33: 240-250.
16. Marie I, Hachulla E, Hatron PY et al. Polymyositis and dermatomyositis: short-term and long-term outcome, and predictive factors of prognosis. J Rheumatol 2001; 28: 2230-2237.